Clinuvel Pharmaceuticals Ltd (CUVL) › Gross ProfitClinuvel Pharmaceuticals Ltd (CUVL): Gross ProfitAnnual figures by period end, from SEC filings.$53.34MYear ended 2026-06-302024-06-30: $47.17M2025-06-30: $49.61M2026-06-30: $53.34M$53.34M2024-06-30 Gross Profit (USD) 2026-06-30Period endedGross ProfitChange YoYSource filing2026-06-30$53.34M+7.5%2026-10-30, From 2025-07-012025-06-30$49.61M+5.2%2026-10-30, From 2024-07-012024-06-30$47.17Mn/a2026-10-30, From 2023-07-01Other metrics: RevenueCost of RevenueR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)